Perseus-Soros Biopharmaceutical Fund

investment firm

Number of Investments

Number of Lead Investments

Perseus-Soros Biopharmaceutical Fund has made 22 investments. Their most recent investment was on Oct 30, 2009, when Xanodyne, Inc raised

Date	Company Name	Round	Money Raised	Industry	Lead Investor
Oct 30, 2009	Xanodyne	Series Unknown	—	Biotechnology	—
Sep 29, 2008	CeNeRx BioPharma	Series B	—	Biopharma	—
Nov 14, 2007	Ambit Biosciences	Series D	—	Biopharma	—
May 1, 2006	Cardiokine	Series B	—	Biotechnology	—
Apr 12, 2006	SkinMedica	Series E	—	Biotechnology	—
Nov 14, 2005	CeNeRx BioPharma	Series A	—	Biopharma	—
May 12, 2005	Ambit Biosciences	Series C	—	Biopharma	—
Apr 6, 2005	SkinMedica	Series E	—	Biotechnology	—
Mar 2, 2005	ArgiNOx Phamaceuticals	Series C	—	Biotechnology	—
Aug 5, 2004	Just Kratom Store	Series C	—	Health Care	Yes
Jul 14, 2004	SkinMedica	Series D	—	Biotechnology	Yes
Jun 12, 2004	ArgiNOx Phamaceuticals	Series B	—	Biotechnology	—
Apr 13, 2004	Cardiokine	Series A	—	Biotechnology	Yes
Nov 7, 2003	Auxilium Pharmaceuticals	Series D	—	Biotechnology	—
Aug 29, 2003	Myogen	Series D	—	Biopharma	—
Jan 10, 2003	Aton Pharma	Private Equity（PE）	—	Biotechnology	—
Oct 22, 2002	Oculex Pharmaceuticals	Series B	—	Biotechnology	Yes
May 9, 2002	Advion Inc.	Series B	—	Biotechnology	Yes
Jan 3, 2002	Myogen	Series D	—	Biopharma	—
Oct 17, 2001	GeneFormatics	Series Unknown	—	Biotechnology	—
Oct 9, 2001	Aderis Pharmaceuticals	Series D	—	Biopharma	—
Dec 31, 2000	Ambit Biosciences	Series B	—	Biopharma	—

Investments

Exits

Founders (Alumni)

Contacts